JOURNAL LONDON, SATURDAY 6 MARCH 1982 Unblocking coronary arteries Coronary arteries become blocked by atheroma and thrombus. Coronary atheroma is the fundamental process and accounts for all the clinical manifestations of ischaemic heart disease; thrombus occurs in acute myocardial infarction.1 Both processes may be preventable. We know that the risk of developing ischaemic heart disease is associated with cigarette smoking, a high serum cholesterol concentration, lack of exercise, and high blood pressure. Wherever possible we should identify and correct these traits. Once coronary artery disease has become established, however, then treatment is symptomatic: the behaviour of the heart may be modified with drugs or the obstructed artery bypassed with a length of saphenous vein. A direct attack on the atheroma or thrombus has always seemed unpromising, but two manoeuvres are now being tried with some success-percutaneous transluminal coronary angioplasty and lysis of the clot within the coronary artery (intracoronary thrombolysis).
Selective coronary arteriography was introduced by Sones et al in 19592 and balloon dilatation of peripheral atherosclerosis by Dotter and Judkins in 1964.3 These two techniques were brought together by Gruntzig in 1977, who was the first to report balloon angioplasty of coronary arteries.4 The technique is simple to describe. A coronary arteriogram is done and a fine balloon catheter is then passed down the artery to the site of the obstruction. Arterial pressure is monitored both proximal and, through the lumen of the catheter, distal to the obstruction. The balloon is then inflated, usually more than once, and the atheroma squashed.
Success is indicated by a rise in the distal pressure and is confirmed by repeat arteriography. Dilatation of the stenosis is due to disruption of the arterial intima and to splitting of the atheromatous plaque.5
Gruintzig4 must take credit for introducing his technique in a responsible manner, which has prevented its uncritical acceptance and allowed proper assessment of its role. At a conference arranged by the National Heart, Lung, and Blood Institute in 1979 a register ofpatients undergoing percutaneous transluminal coronary angioplasty was set up and the indications were agreed-angina pectoris refractory to medical treatment, single-vessel disease with a proximal non-calcified stenosis, good left ventricular function, and objective evidence of myocardial ischaemia. The register now includes 1500 patients from 73 centres with a 63% success rate-defined as a 20% or greater improvement in the stenosis. occurred in 21% of cases, the most common being prolonged pain; 5% of patients had myocardial infarction, 7% required emergency coronary artery bypass grafting, and 1% died in hospital. These results include a learning phase for most centres and are comparable with the overall results of bypass grafting, though such a comparison is unfair to surgery because percutaneous transluminal coronary angioplasty is attempted only in patients at low risk. Percutaneous transluminal coronary angioplasty must be undertaken in centres where cardiac surgery is available and maybe applicable only to a few of the patients who are candidates for surgical treatment. A figure of 8% had been suggested7 but this will be influenced by the indications for arteriography; early investigation of patients with angina will result in more suitable cases being found. 8 No results of long-term follow-up are available. Angina recurs in about 20% of patients within the first three months,9 and it seems inevitable that continuing medical treatment, perhaps with the use of antiplatelet agents, will be needed to prevent restenosis.
In the short term there are grounds for cautious optimism. thrombus is a logical extension of this theme and is now being practised.'8-2' Intracoronary thrombolysis during myocardial infarction must be attempted very soon after formation of the thrombus. This immediately poses problems such as the diagnosis of infarction at this stage and the increased risk of coronary arteriography. The urgency also limits the application of the technique because the number of partients within quick reach of a coronary care unit with facilities for emergency investigation is likely to be small, at least in Britain. Nevertheless, infusion of streptokinase started within a few hours of the onset of symptoms can restore arterial patency within 20 minutes or so, and further improvement may occur with longer periods of infusion21; lysis may be helped by passing a guide wire through the thrombus.18 20 The procedure is not without risk, the most common complications being ventricular arrhythmias and formation of a haematoma at the site of the femoral artery puncture. In the relatively small series reported so far arterial patency has been restored in about threequarters of patients. But does this help? Probably it does. Myocardial perfusion assessed by thallium scintigraphy improves immediately2l; pain may be relieved and raised electrocardiographic ST 
